Novel peptide targeting integrin αvβ3-rich tumor cells by magnetic resonance imaging

Journal of Magnetic Resonance Imaging

Volumn 34, Issue 2, 2011, Pages 395-402

  Wu, Guoqiu ^a   Wang, Xiaodong ^b   Deng, Gang ^a   Wu, Linyuan ^a   Ju, Shenghong ^a   Teng, Gaojun ^a   Yao, Yuyu ^a   Wang, Xiyong ^c   Liu, Naifeng ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^c MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

integrin; magnetic resonance imaging; peptide; ultra superparamagnetic iron oxide particles

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; DRUG CARRIER; P1C; PEPTIDE; SUCCIMER; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CANCER CELL CULTURE; COCULTURE; CONCENTRATION RESPONSE; CONJUGATION; CONTRAST TO NOISE RATIO; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CANCER; MOUSE; NOISE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR BINDING; TARGET CELL DESTRUCTION; TRANSMISSION ELECTRON MICROSCOPY;

CELL LINE, TUMOR; COLORING AGENTS; DISEASE PROGRESSION; FERRIC COMPOUNDS; FERROCYANIDES; HUMANS; INTEGRIN ALPHAVBETA3; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASM METASTASIS; PEPTIDES; SUCCIMER;

EID: 79960608886     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22620     Document Type: Article

References (36)

1. Reinmuth N, Liu W, Ahmad SA, et al. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Cancer Res 2003; 63: 2079-2087. (Pubitemid 36538610)
2. Brooks PC, Clark RA, Cheresh DA,. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994; 264: 569-571.
3. Friedlander M, Theesfeld CL, Sugita M, et al. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci U S A 1996; 93: 9764-9769. (Pubitemid 26296683)
4. Gasparini G, Brooks PC, Biganzoli E, et al. Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. Clin Cancer Res 1998; 4: 2625-2634. (Pubitemid 28523488)
5. Vellon L, Menendez JA, Lupu R,. AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer. Oncogene 2005; 24: 3759-3773. (Pubitemid 40826875)
6. Jia B, Shi J, Yang Z, et al. 99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression. Bioconjug Chem 2006; 17: 1069-1076. (Pubitemid 44162628)
7. Dijkgraaf I, Kruijtzer JA, Frielink C, et al. Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide. Int J Cancer 2007; 120: 605-610. (Pubitemid 44969032)
8. Beer AJ, Grosu AL, Carlsen J, et al. [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 2007; 13 (22 Pt 1): 6610 -6616.
9. Roman J, Ritzenthaler JD, Roser-Page S, Sun X, Han S,. alpha5beta1 integrin expression is essential for tumor progression in experimental lung cancer. Am J Respir Cell Mol Biol 2010; 43: 684-691.
10. Kerr JS, Wexler RS, Mousa SA, et al. Novel small molecule alpha v integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors. Anticancer Res 1999; 19: 959-968. (Pubitemid 29257522)
11. Temming K, Schiffelers RM, Molema G, Kok RJ,. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. Drug Resist Updat 2005; 8: 381-402. (Pubitemid 43358061)
12. Jeong JM, Hong MK, Chang YS, et al. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4, 7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med 2008; 49: 830-836.
13. Li ZB, Chen K, Chen X,. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression. Eur J Nucl Med Mol Imaging 2008; 35: 1100-1108.
14. Janssen ML, Oyen WJ, Dijkgraaf I, et al. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model. Cancer Res 2002; 62: 6146-6151. (Pubitemid 35244464)
15. Achilefu S, Bloch S, Markiewicz MA, et al. Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression. Proc Natl Acad Sci U S A 2005; 102: 7976-7981. (Pubitemid 40781048)
16. Dayton PA, Pearson D, Clark J, et al. Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells. Mol Imaging 2004; 3: 125-134.
17. Zhang C, Jugold M, Woenne EC, et al. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res 2007; 67: 1555-1562. (Pubitemid 46383379)
18. Park JA, Lee JJ, Jung JC, et al. Gd-DOTA conjugate of RGD as a potential tumor-targeting MRI contrast agent. Chembiochem 2008; 9: 2811-2813.
19. Dijkgraaf I, Beer AJ, Wester HJ,. Application of RGD-containing peptides as imaging probes for alphavbeta3 expression. Front Biosci 2009; 14: 887-899.
20. Zhang S, Bian Z, Gu C, et al. Preparation of anti-human cardiac troponin I immunomagnetic nanoparticles and biological activity assays. Colloids Surf B Biointerfaces 2007; 55: 143-148. (Pubitemid 46290622)
21. Fauconnier N, Pons JN, Roger J, Bee A,. Thiolation of maghemite nanoparticles by dimercaptosuccinic acid. J Colloid Interface Sci 1997; 194: 427-433. (Pubitemid 27520904)
22. Cirioni O, Wu G, Li L, et al. S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis. Peptides 2010; 31: 1231-1236.
23. Wu G, Fan X, Li L, et al. Interaction of antimicrobial peptide s-thanatin with lipopolysaccharide in vitro and in an experimental mouse model of septic shock caused by a multidrug-resistant clinical isolate of Escherichia coli. Int J Antimicrob Agents 2010; 35: 250-254.
24. Wu G, Wu H, Li L, et al. Membrane aggregation and perturbation induced by antimicrobial peptide of S-thanatin. Biochem Biophys Res Commun 2010; 395: 31-35.
25. Bradham DM, Igarashi A, Potter RL, Grotendorst GR,. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991; 114: 1285-1294. (Pubitemid 21909886)
26. Brigstock DR,. The CCN family: a new stimulus package. J Endocrinol 2003; 178: 169-175. (Pubitemid 37063059)
27. Babic AM, Chen CC, Lau LF,. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 1999; 19: 2958-2966. (Pubitemid 29144541)
28. Gao R, Brigstock DR,. Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem 2004; 279: 8848-8855. (Pubitemid 38295943)
29. Jedsadayanmata A, Chen CC, Kireeva ML, Lau LF, Lam SC,. Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J Biol Chem 1999; 274: 24321-24327.
30. Chen CC, Chen N, Lau LF,. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem 2001; 276: 10443-10452.
31. Wu JC, Bengel FM, Gambhir SS,. Cardiovascular molecular imaging. Radiology 2007; 244: 337-355. (Pubitemid 47080867)
32. Ito A, Shinkai M, Honda H, Kobayashi T,. Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 2005; 100: 1-11. (Pubitemid 41573511)
33. Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt BK,. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med 2002; 48: 52-61. (Pubitemid 34721587)
34. Wang X, Wu G, Ju S, Teng G, Yao Y, Liu N,. Preparation of M R molecular probe targeting integrin alpha v beta 3 in vitro imaging. J Southeast Univ Med 2009; 28: 470-473.
35. Jiang T, Zhang C, Zheng X, et al. Noninvasively characterizing the different alphavbeta3 expression patterns in lung cancers with RGD-USPIO using a clinical 3.0T MR scanner. Int J Nanomed 2009; 4: 241-249.
36. Raatschen HJ, Simon GH, Fu Y, et al. Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats. Radiology 2008; 247: 391-399.